The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JC.2004-0628PMID 15483098
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Leukocytes and coronary heart disease.

  2004cited by this paper
• Comparison of serum concentrations of C-reactive protein, TNF-alpha, and interleukin 6 between elderly Korean women with normal and impaired glucose tolerance.

  2004cited by this paper
• The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey.

  2003cited by this paper
• Inflammation and insulin resistance.

  2003cited by this paper
• Inflammation and coronary artery disease.

  2003cited by this paper
• Effect of family history of type 2 diabetes on white blood cell count in adult women.

  2003cited by this paper
• Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.

  2003cited by this paper
• Adiponectin levels in women with polycystic ovary syndrome.

  2003cited by this paper
• Circulating ghrelin concentrations in the polycystic ovary syndrome.

  2003cited by this paper
• WBC count, atherosclerosis and coronary risk factors.

  2002cited by this paper
• Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes.

  2002cited by this paper
• Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.

  2002influential reference
• Growth Hormone Secretion after Baclofen Administration in Different Phases of the Menstrual Cycle in Healthy Women

  2001cited by this paper
• Low grade chronic inflammation in women with polycystic ovarian syndrome.

  2001cited by this paper
• White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: atherosclerosis risk in communities study.

  2001cited by this paper
• Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease.

  2001cited by this paper
• Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes.

  2000cited by this paper
• The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes.

  2000cited by this paper
• Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

  2000cited by this paper
• Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management

  1999cited by this paper
• Clustering of metabolic factors and coronary heart disease.

  1999cited by this paper
• Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.

  1999cited by this paper
• Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

  1997cited by this paper
• Coronary heart disease risk factors in women with polycystic ovary syndrome.

  1995cited by this paper
• Inflammation and coronary artery disease.

  1994cited by this paper
• Inflammation and Coronary Artery Disease

  1994cited by this paper
• Leukocyte count correlates in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study.

  1992cited by this paper
• Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome

  1992cited by this paper

• The importance of ovary-immune interactions in the context of age and disease.

  2026cites this paper
• Biomarkers for effective prognosis of polycystic ovary syndrome: a full review.

  2026cites this paper
• Inflammation at the crossroads of reproduction: SIRI as a prognostic signature of female infertility in hybrid regression–machine learning models

  2026cites this paper
• Association between polycystic ovary syndrome and systemic immune inflammation index and other inflammation markers; a case-control study

  2025cites this paper
• Using machine learning to predict patients with polycystic ovary disease in Chinese women.

  2025cites this paper
• Nutraceutical Impact of Pumpkin Seed Oil on Expression Levels of EZH-2 and KRT-14 Genes against DSS-induced Inflammatory Bowel Disease in the Rat Model

  2025cites this paper
• Recent advances in reprogramming lactate metabolism in polycystic ovary syndrome

  2025cites this paper
• CRISPR as a Tool to Uncover Gene Function in Polycystic Ovary Syndrome: A Literature Review of Experimental Models Targeting Ovarian and Metabolic Genes

  2025cites this paper
• High-dimensional immune profiling of follicular fluid and systemic circulation reveals distinct immune signatures in women with polycystic ovary syndrome

  2025cites this paper
• Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation

  2025cites this paper
• Schizophrenia may be a risk of polycystic ovary syndrome (PCOS) and primary ovarian insufficiency (POI): A Mendelian randomisation study

  2025cites this paper
• Diagnostic and prognostic biomarkers in Polycystic Ovary Syndrome.

  2025cites this paper
• Coexistence of Elevated Maternal Body Mass Index and Polycystic Ovary Syndrome May be Associated With Increased Risk of Neonatal Complications and Caesarean Section Delivery Following Intrauterine Insemination: A Retrospective Cohort Study

  2025cites this paper
• Assessment of Inflammatory Indices in Women with Polycystic Ovarian Syndrome

  2025cites this paper
• The Inflammatory State of Follicular Fluid Combined with Negative Emotion Indicators can Predict Pregnancy Outcomes in Patients with PCOS

  2024cites this paper
• Association Between Chlamydia trachomatis and Helicobacter pylori with Inflammation in Polycystic Ovary Syndrome: A Cross-Sectional Study

  2024cites this paper
• Proteomic analysis shows decreased type I fibers and ectopic fat accumulation in skeletal muscle from women with PCOS

  2024cites this paper
• Polycystic Ovary Syndrome Till Date and Possibilities in Coming Years

  2024cites this paper
• Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome

  2024cites this paper
• The impact of hyperandrogenemia on pregnancy complications and outcomes in patients with PCOS: a systematic review and meta-analysis

  2024cites this paper
• The Role of 11-Oxygenated Androgens and Endocrine Disruptors in Androgen Excess Disorders in Women

  2024cites this paper
• Androgens Modulate the Immune Profile in a Mouse Model of Polycystic Ovary Syndrome

  2024cites this paper
• Polycystic Ovary Syndrome, Metabolic Syndrome, and Inflammation in the Hispanic Community Health Study/Study of Latinos.

  2024cites this paper
• Interleukin-6 -174 G/C promoter gene polymorphism and polycystic ovary syndrome: A cross sectional investigation in adult women

  2023cites this paper
• The association between systemic immune-inflammation index and in vitro fertilization outcomes in women with polycystic ovary syndrome: a cohort study

  2023cites this paper
• Evaluation of periodontal status in women with polycystic ovary syndrome versus healthy women: a cross-sectional study

  2023cites this paper
• Immune Dysfunction in Polycystic Ovary Syndrome

  2023cites this paper
• Androgen-Induced Cardiovascular Risk in Polycystic Ovary Syndrome: The Role of T Lymphocytes

  2023cites this paper
• Unusual Extreme Leukocytosis in Metformin Overdose.

  2023cites this paper
• Type I fiber decrease and ectopic fat accumulation in skeletal muscle from women with PCOS

  2023cites this paper
• Risk of Periodontal Diseases in Women With Polycystic Ovary Syndrome: An Overview

  2023cites this paper
• The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review

  2023cites this paper
• The Effect of Leptin on the Regulation of Immune Responses in Women with Polycystic Ovary Syndrome.

  2022cites this paper
• Systemic and ovarian inflammation in women with polycystic ovary syndrome.

  2022cites this paper
• Polycystic ovary syndrome and immune deregulation: what do hormones want to say?

  2022cites this paper
• Quantitative Changes in White Blood Cells: Correlation with the Hallmarks of Polycystic Ovary Syndrome

  2022cites this paper
• Quercetin and polycystic ovary syndrome; inflammation, hormonal parameters and pregnancy outcome: A randomized clinical trial

  2022cites this paper
• Extracellular DNA Traps: Origin, Function and Implications for Anti-Cancer Therapies

  2022cites this paper
• Evaluation of Biochemical and Hematological Parameters in Polycystic Ovarian Syndrome Among Urban College Girls

  2022cites this paper
• Review of the Effects of Polycystic Ovary Syndrome on Cognition: Looking Beyond the Androgen Hypothesis.

  2022cites this paper
• Effects of immune cells and cytokines on the endometrial immune microenvironment in polycystic ovary syndrome

  2022cites this paper
• Intrinsic abnormalities of adipose tissue and adipose tissue dysfunction in PCOS

  2022cites this paper
• Does alpha-1-acid glycoprotein determine for infertility in polycystic ovary syndrome?

  2022cites this paper
• Monocyte/HDL ratio in women with polycystic ovary syndrome and healthy controls

  2021cites this paper
• The connection of alpha‐1 acid glycoprotein inflammatory marker with anthropometric, hormonal, and metabolic characteristic of women with polycystic ovary syndrome

  2021cites this paper
• Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome.

  2021cites this paper
• PCOS: A Chronic Disease That Fails to Produce Adequately Specialized Pro-Resolving Lipid Mediators (SPMs)

  2021cites this paper
• Possible Role of Metformin as an Immune Modulator in the Tumor Microenvironment of Ovarian Cancer

  2021cites this paper
• Shared postulations between bipolar disorder and polycystic ovary syndrome pathologies.

  2021cites this paper
• Correlation between Polycystic Ovary Syndrome and Periodontal Disease

  2021cites this paper
• Chronic Low Grade Inflammation in Pathogenesis of PCOS

  2021cites this paper
• Polycystic Ovarian Syndrome and Menopause in Forty Plus Women

  2021cites this paper
• ESTIMATION OF REACTIVE OXYGEN SPECIES AND TOTAL ANTIOXIDANT CAPACITY IN SERUM OF IRAQI FEMALES WITH PCOS

  2021cites this paper
• ASSESSMENT OF SERUM IRISIN IN OVERWEIGHT AND OBESE PATIENT WITH POLYCYSTIC OVARY SYNDROME

  2020cites this paper
• Exercise and Polycystic Ovary Syndrome.

  2020cites this paper
• Role of IL-6 signalling in Polycystic Ovarian Syndrome associated inflammation.

  2020cites this paper
• Comparing pregnancy, childbirth, and neonatal outcomes in women with different phenotypes of polycystic ovary syndrome and healthy women: a prospective cohort study

  2020cites this paper
• Inflammatory Markers in Women with Polycystic Ovary Syndrome

  2020cites this paper
• Peripheral Blood Inflammatory-Immune Cells as a Predictor of Infertility in Women with Polycystic Ovary Syndrome

  2020cites this paper
• Effect of Central Obesity and Hyperandrogenism on Selected Inflammatory Markers in Patients with PCOS: A WHtR-Matched Case-Control Study

  2020cites this paper
• Midlife women’s health consequences associated with polycystic ovary syndrome

  2020cites this paper
• Periodontitis and polycystic ovary syndrome: An unveiling review

  2020cites this paper
• The effects of physical exercise on cardiometabolic outcomes in women with polycystic ovary syndrome not taking the oral contraceptive pill: a systematic review and meta-analysis

  2019cites this paper
• Mesenchymal Stem Cells Alleviate DHEA-Induced Polycystic Ovary Syndrome (PCOS) by Inhibiting Inflammation in Mice

  2019cites this paper
• Inflammatory Stimuli Trigger Increased Androgen Production and Shifts in Gene Expression in Theca-Interstitial Cells.

  2019cites this paper
• Generational Health Impact of PCOS on Women and Their Children

  2019cites this paper
• Do inflammation and hormone parameters have effects on IVF results in patients with unexplained infertility?

  2019cites this paper
• Roles of Oxidative Stress in Policystic Ovary Syndrome

  2019cites this paper
• DNA Methylation in the Pathogenesis of Polycystic Ovary Syndrome.

  2019cites this paper
• Treatment with Metformin and Combination of Metformin Plus Pioglitazone on Serum Levels of IL-6 and IL-8 in Polycystic Ovary Syndrome: A Randomized Clinical Trial

  2019cites this paper
• PCOS in obesity: Indian scenario

  2019cites this paper
• Immunophenotypic profile of leukocytes in hyperandrogenemic female rat an animal model of polycystic ovary syndrome☆

  2019cites this paper
• The effects of exercise on cardiometabolic outcomes in women with polycystic ovary syndrome not taking the oral contraceptive pill: protocol for a systematic review and meta-analysis

  2019cites this paper
• The association between in vitro fertilization outcome and the inflammatory markers of complete blood count among nonobese unexplained infertile couples.

  2018cites this paper
• Polycystic Ovary Syndrome and Periodontal disease: Underlying Links- A Review

  2018cites this paper
• Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment

  2018cites this paper
• 7 Polycystic Ovary Syndrome and Cardiovascular Disease

  2018cites this paper
• Combined Oral Contraceptive Effects on Low-Grade Chronic Inflammatory Mediators in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

  2018cites this paper
• Association of IL-29 with the lipid metabolic features of polycystic ovary syndrome

  2018cites this paper
• Fetal programming of adult disease: causes and consequences of metabolic dysregulation in an ovine model of PCOS

  2018cites this paper
• Is cardiovascular risk in women with PCOS a real risk? Current insights.

  2017cites this paper
• CVD and Oxidative Stress

  2017cites this paper
• The predictive effect of inflammatory markers and lipid accumulation product index on clinical symptoms associated with polycystic ovary syndrome in nonobese adolescents and younger aged women.

  2017cites this paper
• Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial

  2016cites this paper
• Higher circulating leukocytes in women with PCOS is reversed by aerobic exercise.

  2016cites this paper
• Effects of simvastatin, ezetimibe and simvastatin/ezetimibe on mitochondrial function and leukocyte/endothelial cell interactions in patients with hypercholesterolemia.

  2016cites this paper
• Insulin resistance Hyperinsulinemia Ovarian and adrenal dysfunction Testosterone Abdominal obesity Inflammation Inheritance Unknown factors Diabetes

  2016cites this paper
• Endocrine and Metabolic Profile of Different Phenotypes of Polycystic Ovarian Syndrome

  2016cites this paper
• Effect of maternal PCOS and PCOS-like phenotype on the offspring's health.

  2016cites this paper
• The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes

  2016cites this paper
• Syddansk Universitet Endocrine and metabolic characteristics in polycystic ovary syndrome

  2016cites this paper
• Effect of colchicine on polycystic ovary syndrome: an experimental study

  2016cites this paper
• Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome.

  2016cites this paper
• Drug-Induced Hyperglycemia and Diabetes Mellitus

  2016cites this paper
• Clinical significance of ADAMTS1, ADAMTS5, ADAMTS9 aggrecanases and IL-17A, IL-23, IL-33 cytokines in polycystic ovary syndrome

  2016cites this paper
• Insulin Resistance in PCOS Patients Enhances Oxidative Stress and Leukocyte Adhesion: Role of Myeloperoxidase

  2016cites this paper
• The effects of moderate treadmill and running wheel exercises on oxidative stress in female rats with steroid-induced polycystic ovaries

  2016cites this paper
• Helicobacter pylori infection and polycystic ovary syndrome in adolescent and young adult patients

  2016cites this paper
• Granulocyte colony-stimulating factor: A relation between serum and follicular fluid levels and in-vitro fertilization outcome in patients with polycystic ovary syndrome.

  2015cites this paper
• Android fat distribution affects some hemostatic parameters in women with polycystic ovary syndrome compared with healthy control subjects matched for age and body mass index.

  2015cites this paper